Advertisement
Advertisement
PLSE
Pulse Biosciences, Inc Common Stock (DE)
53.29
USDSponsored
+0.22
+0.41%
Nov 06, 15:59 UTC -5
Closed
After-Market
52.60
-0.69
-1.30%
Pulse Biosciences, Inc Common Stock (DE) (PLSE) Earnings
PLSE Earnings Reports
Positive Surprise Ratio
PLSE beat 13 of 26 last estimates.
50%
Next Report
Date of Next Report
Feb 17, 2027
Estimate for Q4 26 (Revenue/ EPS)
$708.90K
/-$0.38
Implied change from Q3 26 (Revenue/ EPS)
+77.23%
/+18.75%
Implied change from Q4 25 (Revenue/ EPS)
+168.52%
/+46.15%
Pulse Biosciences, Inc Common Stock (DE) earnings per share and revenue
On Nov 05, 2026, PLSE reported earnings of -0.32 USD per share (EPS) for Q3 26, beating the estimate of -0.37 USD, resulting in a 14.05% surprise. Revenue reached 400.00 thousand, compared to an expected 527.00 thousand, with a -24.10% difference. The market reacted with a +0.41% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 3 analysts forecast an EPS of -0.38 USD, with revenue projected to reach 708.90 thousand USD, implying an increase of 18.75% EPS, and increase of 77.23% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
GLOBUS MEDICAL INC
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.22
Actual
$1.23
Surprise
+0.75%
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
CVRx, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.52
Surprise
-2.91%
FAQ
What were Pulse Biosciences, Inc Common Stock (DE)'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Pulse Biosciences, Inc Common Stock (DE) reported EPS of -$0.32, beating estimates by 14.05%, and revenue of $400.00K, -24.1% below expectations.
How did the market react to Pulse Biosciences, Inc Common Stock (DE)'s Q3 2026 earnings?
The stock price moved up 0.41%, changed from $53.07 before the earnings release to $53.29 the day after.
When is Pulse Biosciences, Inc Common Stock (DE) expected to report next?
The next earning report is scheduled for Feb 17, 2027.
What are the forecasts for Pulse Biosciences, Inc Common Stock (DE)'s next earnings report?
Based on 3
analysts, Pulse Biosciences, Inc Common Stock (DE) is expected to report EPS of -$0.38 and revenue of $708.90K for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.